RxDoctor Payments Data

Jennifer Divine, MD

MOHS-Micrographic Surgery · Fort Collins, CONPI 1063779072

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.9% of the total across 184 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 30.0% of the total. Reporting peaked in 2024 at $1,005 and has fallen 70.2% since, to $299 in 2025.

$3,722in general payments, 2019–2025

Across 184 payments — averaging $20.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Sun Pharmaceutical Industries Inc.$348
  • Pfizer$236
  • LEO Pharma Inc.$209
  • Sanofi$203
  • Galderma Laboratories, L.p.$189
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$3,49494%
  • Education$2286%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,722 in reported general payments places this provider in the 65th percentile of 37 mohs-micrographic surgery providers in Colorado.

See all mohs-micrographic surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$312,657
Medicare patients
674
Services billed
3,868

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab27$110,382
Clobetasol Propionate86$5,214
Tacrolimus12$2,343
Doxycycline Monohydrate46$1,883
Pimecrolimus11$1,551
Tretinoin11$1,191
Triamcinolone Acetonide66$1,029
Fluorouracil12$1,025
Ketoconazole43$909
Clindamycin Phosphate22$737
Doxycycline Hyclate34$712
Metronidazole13$673
Mupirocin60$572
Minoxidil23$517
ValacyclovirValacyclovir Hcl19$503

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Fort Collins

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →